Home » Epilepsy Blog » News and Research » Living Well has welcomed our 3000th visitor

Living Well has welcomed our 3000th visitor

A recent look at Living Well’s google analytics showed that https://www.livingwellwithepilepsy.com/, an epilepsy blog, has welcomed over 3000 unique visitors! We have an average of 25 people swing by each day. That’s a dramatic improvement from this time last year when we had an average of 2 people visiting the site each day. And at least one of those people was me.

Exponential Growth
Just in case you’re no math whiz (I know I’m not), that’s a 1150% increase in average daily visits! Thanks everyone, we really are making an impact.

No Mean Feat

Living Well is not going to take down The Huffington Post or Mashable, but I’m thrilled with our success and to be part of a community that is raising epilepsy awareness with each post.

Where in the world  
To give a sense of scope, those more than 3000 people made 4,240 visits and they came from 96 countries/territories including:
United States, Canada, United Kingdom, Australia, India, Philippines, Czech Republic, Germany, Indonesia, and Croatia among others.
Thanks
So thanks again, and keep those suggestions coming. They can only make our community more connected.

author avatar
Jessica K. Smith Founder and CEO; Executive Director
Jessica Keenan Smith is a patient advocate and epilepsy community leader with more than 15 years of experience. As Founder and CEO of Living Well With Epilepsy and Executive Director of ASENT she bridges the gap between the scientific and patient communities, with a particular focus on the needs of the epilepsies. Jessica Keenan Smith is Founder and CEO of Living Well With Epilepsy, an award winning online resource for people affected by epilepsy to share stories and access in-depth information on the disease. Since 2009, Living Well With Epilepsy (https://livingwellwithepilepsy.com) has been featured in Forbes, Wired, NBC, NPR and the cover story of Epilepsy Advocate Magazine and has partnered with companies such as UCB, Lundbeck, Sunovion, Eisai, and more. Ms. Smith is also the Executive Director of the American Society for Experimental Neurotherapeutics (ASENT) (https://asent.org), an organization that brings together leaders from industry, academia, government and advocacy who are engaged in bringing drugs and devices to market across all neurologic disease states. In this role she is responsible for leading a successful scientific journal and annual scientific conference with speakers from all over the world.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.